XEN Glaucoma Implant for the Management of Glaucoma in Naïve Patients versus Patients with Previous Glaucoma Surgery

This retrospective study analyzed the surgical and refractive outcomes of a XEN Gel Implant (Allergan, Abbvie Company, Irvine, CA, USA) in naïve patients versus those with previous glaucoma surgery. We evaluated the efficacy of XEN implantation in 86 glaucoma patients during a long-term follow-up pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewczuk, Katarzyna, Konopińska, Joanna, Jabłońska, Joanna, Rudowicz, Jacek, Laszewicz, Patrycja, Dmuchowska, Diana Anna, Mariak, Zofia, Rękas, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509378/
https://www.ncbi.nlm.nih.gov/pubmed/34640435
http://dx.doi.org/10.3390/jcm10194417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509378/
https://www.ncbi.nlm.nih.gov/pubmed/34640435
http://dx.doi.org/10.3390/jcm10194417

Ejemplares similares